Literature DB >> 15056452

Microtubule-associated protein tau gene: a risk factor in human neurodegenerative diseases.

Susanna Schraen-Maschke1, Claire-Marie Dhaenens, André Delacourte, Bernard Sablonnière.   

Abstract

Tau is a microtubule-associated protein mainly expressed in neurons of central nervous system, which is crucial in the maintenance of these cells. It has a central role in the polymerization and stabilization of microtubules and in the traffic of organelles along axons and dendrites. Aggregates of hyperphosphorylated forms of tau protein participate in the formation of neurofibrillary tangles, which characterize numerous neurodegenerative disorders named tauopathies. The analysis of tau gene and the study of familial cases of tauopathies have led to the discovery of tau gene mutations that cause inherited dementia designated as Frontotemporal dementia (FTD) with parkinsonism linked to chromosome 17 (FTDP-17). However, these familial cases remain rare compared to the sporadic tauopathies, the later involving both genetic and environmental etiologic factors. As tau pathology represents a primary pathogenic event in various neurodegenerative diseases, the hypothesis that tau genotype could influence the development of these diseases was tested by several groups. This review summarizes advances in the molecular genetics of the tau gene, as well as recent studies addressing the disease incidence of novel tau polymorphisms in different neurodegenerative diseases. Hopefully, the identification of several genetic defects of the tau gene will be helpful in improving our understanding of the role of tau protein in the pathogenesis of various neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15056452     DOI: 10.1016/j.nbd.2003.12.009

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  9 in total

1.  Tau as a biomarker of neurodegenerative diseases.

Authors:  Susanna Schraen-Maschke; Nicolas Sergeant; Claire-Marie Dhaenens; Stéphanie Bombois; Vincent Deramecourt; Marie-Laure Caillet-Boudin; Florence Pasquier; Claude-Alain Maurage; Bernard Sablonnière; Eugeen Vanmechelen; Luc Buée
Journal:  Biomark Med       Date:  2008-08       Impact factor: 2.851

2.  Association study of polymorphisms in LRP1, tau and 5-HTT genes and Alzheimer's disease in a sample of Colombian patients.

Authors:  D A Forero; G Arboleda; J J Yunis; R Pardo; H Arboleda
Journal:  J Neural Transm (Vienna)       Date:  2005-12-14       Impact factor: 3.575

3.  Clearance of intracellular tau protein from neuronal cells via VAMP8-induced secretion.

Authors:  Julie Pilliod; Alexandre Desjardins; Camille Pernègre; Hélène Jamann; Catherine Larochelle; Edward A Fon; Nicole Leclerc
Journal:  J Biol Chem       Date:  2020-10-22       Impact factor: 5.157

4.  Management of frontotemporal dementia: targeting symptom management in such a heterogeneous disease requires a wide range of therapeutic options.

Authors:  Gregory A Jicha; Peter T Nelson
Journal:  Neurodegener Dis Manag       Date:  2011-04

5.  Clearance of intracellular tau protein from neuronal cells via VAMP8-induced secretion.

Authors:  Julie Pilliod; Alexandre Desjardins; Camille Pernègre; Hélène Jamann; Catherine Larochelle; Edward A Fon; Nicole Leclerc
Journal:  J Biol Chem       Date:  2020-12-18       Impact factor: 5.157

Review 6.  Regulation of human MAPT gene expression.

Authors:  Marie-Laure Caillet-Boudin; Luc Buée; Nicolas Sergeant; Bruno Lefebvre
Journal:  Mol Neurodegener       Date:  2015-07-14       Impact factor: 14.195

Review 7.  Alternative splicing of exon 10 in the tau gene as a target for treatment of tauopathies.

Authors:  Jianhua Zhou; Qingming Yu; Tie Zou
Journal:  BMC Neurosci       Date:  2008-12-03       Impact factor: 3.288

8.  Network analysis of neurodegenerative disease highlights a role of Toll-like receptor signaling.

Authors:  Thanh-Phuong Nguyen; Laura Caberlotto; Melissa J Morine; Corrado Priami
Journal:  Biomed Res Int       Date:  2014-01-16       Impact factor: 3.411

9.  MAPT as a predisposing gene for sporadic amyotrophic lateral sclerosis in the Chinese Han population.

Authors:  Pu Fang; Wenyuan Xu; Chengsi Wu; Min Zhu; Xiaobing Li; Daojun Hong
Journal:  Neural Regen Res       Date:  2013-11-25       Impact factor: 5.135

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.